Clinical Trial Update: Bioequivalence Study of Paricalcitol Capsules, 4 mcg Under Fasting Conditions [Phase 1]

View source ↗

Summary

A Phase 1 bioequivalence study of paricalcitol 4 mcg capsules under fasting conditions in healthy volunteers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hyperparathyroidism

Drugs mentioned

• Paricalcitol capsules (paricalcitol)

Snippet

Sponsor: Dr. Reddy's Laboratories Limited | Conditions: Healthy | Phase 1 | Status: COMPLETED